LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Welcome to the LeMaitre Vascular First Quarter 2024 Financial Results Conference Call. As a reminder, today’s call is being recorded.
Lemaitre Vascular Inc (LMAT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Driehaus Capital Richard Driehaus | 96,988 | $5,505,039 | -20% | 0.06% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 83,372 | $4,732,195 | -14% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 73,500 | $4,171,860 | -11% | 0% |
| 4. | Citadel Investment Group Ken Griffin | 50,982 | $2,893,738 | +35% | 0% |
| 5. | Bridgewater Associates Ray Dalio | 21,401 | $1,214,721 | -10% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.06 | 30 | Director | 181 | 2020-08-26 | Filing | |
| $25.28 | 151 | Director | 151 | 2020-05-21 | Filing | |
| $28.35 | 7,074 | Officer, Director | 43,557 | 2020-08-14 | Filing | |
| $5.50 | 4,000 | Large Shareholder, Officer, Director | 3,927,163 | 2012-06-08 | Filing | |
| $5.34 | 2,000 | Large Shareholder, Officer, Director | 3,917,163 | 2012-05-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $75.30 | 8,000 | Officer, Director | 2,079,128 | 2024-05-08 | Filing | |
| $75.86 | 20,256 | Officer, Director | 2,087,128 | 2024-05-07 | Filing | |
| $75.24 | 26,044 | Officer, Director | 2,107,384 | 2024-05-07 | Filing | |
| $75.94 | 16,200 | Officer, Director | 2,133,428 | 2024-05-06 | Filing | |
| $75.23 | 29,500 | Officer, Director | 2,149,628 | 2024-05-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,297,277 | $187,153,442 | 0% | |
| 2. | 1,927,971 | $109,431,662 | 1.64% | |
| 3. | 1,548,870 | $87,913,861 | 0% | |
| 4. | 1,259,961 | $71,515,385 | 1.43% | |
| 5. | 912,503 | $51,793,670 | 3.14% |
News See All
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36. LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q3 2023 Financial Results Conference Call. After the speaker’s presentation, there will be a question-and-answer session.
Here’s Why LeMaitre Vascular (LMAT) Outperformed in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q2 2023 Financial Results Conference Call. As a reminder, today’s call is being recorded. At this time, I would like to turn the call over to Mr. J.J.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q1 2023 Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. J.J.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2022 Earnings Call Transcript
Operator: Welcome to LeMaitre Vascular Q4 2022 Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. J.J.
Where Do Hedge Funds Stand On LeMaitre Vascular Inc (LMAT)?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is LMAT A Good Stock To Buy Now?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money managers and analyze their...
Should You Be Tempted To ‘Sell’ LeMaitre Vascular (LMAT) Stock
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen U.S.